Novartis' heart failure medicine LCZ696 granted FDA priority review

Novartis' heart failure medicine LCZ696 granted FDA priority review

Feb 13, 2015
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0